Epstein-Barr virus and lymphoproliferative disorders after transplantation-Reference-Cited by-同舟云学术

Epstein-Barr virus and lymphoproliferative disorders after transplantation

Published:2004-10 Issue: Volume:4 Page:59-65
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6135.2004.00728.x/fullpdf

Reference26 articles.

1. Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation;Green;Am J Transplant,2001

2. The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach;Nalesnik;Transpl Infect Dis,2001

3. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting;Paya;Transplantation,1999

4. Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients;Preiksaitis;Clin Infect Dis,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stable renal engraftment in a patient following successful tandem autologous/reduced-intensity conditioning allogeneic transplantation for treatment of multiple myeloma with del(17p) that developed as a post-transplantation lymphoproliferative disease following renal transplantation;International Journal of Hematology;2013-05-11

2. Viral Infections of the Immunocompromised Host;Infectious Disease and Therapy;2010-03

3. Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients;American Journal of Transplantation;2009-11

4. Pharmacotherapy of post-transplant viral infections;Expert Opinion on Pharmacotherapy;2008-09-08

5. Strategies for Epstein–Barr virus monitoring, detection and therapy in post-transplant lymphoproliferative disorder;Future Virology;2007-07